EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Preventive Effect of Butyrate in Colon Cancer Cell Metabolism

Telmo José Gonçalves, Ana Margarida Abrantes iD, Ana Salomé Pires iD, Ana Cristina Gonçalves iD, Ludgero Canário Tavares iD, João Casalta-Lopes, Ana Bela Sarmento-Ribeiro iD, Rui A Carvalho, Maria Filomena Botelho iD

International Journal of Molecular Sciences · 21.04.2026 · 27 (8) · 3696

DOI: 10.3390/ijms27083696 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.04.2026. Verfasst von Telmo José Gonçalves und 8 weiteren Autor:innen. Beteiligte Einrichtung: Univ Coimbra, Coimbra Institute for Clinical and Biomedical Research (iCBR) area of Environment Genetics and Oncobiology (CIMAGO), Biophysics Institu…. Hauptthemen laut MEDLINE: Colonic Neoplasms, Butyrates. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Butyrate, a short-chain fatty acid produced by the fermentation of soluble dietary fiber by gut bacteria, also functions as a histone deacetylase inhibitor known to induce apoptosis and promote differentiation in colon tumor cells. During tumorigenesis, cancer cells undergo metabolic reprogramming to meet energetic and biosynthetic demands, increasing glycolytic metabolism and reducing oxidative metabolism—a phenomenon known as the Warburg effect. This study aimed to evaluate the impact of butyrate on the aggressiveness-related metabolic phenotype of three colon cancer cell lines (LS1034, C2BBe1, and WiDr). Butyrate’s effects were assessed through fluorine-18 fluorodeoxyglucose ([18F]FDG) uptake, flow cytometry analysis of cytoplasmic and membrane expression of glucose transporters (GLUT1, GLUT3, GLUT5, and GLUT12), lactate production, and analysis of Krebs cycle turnover and glycolysis–Krebs cycle coupling using nuclear magnetic resonance isotopomer profiling. [18F]FDG uptake decreased in C2BBe1 and WiDr cells, whereas an opposite response was observed in LS1034 cells, which also exhibited reduced GLUT5 expression. These uptake patterns were consistent with lactate production measurements, and an enhancement of oxidative metabolism was detected in C2BBe1 and WiDr cells. Although butyrate was consumed by all three cell lines, its metabolic handling appeared to differ in LS1034 cells, possibly reflecting cytotoxic stress and/or distinct metabolic regulation mechanisms. Overall, these findings indicate that butyrate exerts cell-line-dependent metabolic effects in colorectal cancer cells. In C2BBe1 and WiDr cells, butyrate exposure was broadly consistent with the attenuation of glycolytic/Warburg-associated features, whereas LS1034 cells displayed a divergent response and were interpreted separately. These data support further investigation of butyrate as a modulator of colorectal cancer cell metabolism, while highlighting the heterogeneity of metabolic responses across tumor models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colonic NeoplasmsButyratesHumansCell Line, TumorGlycolysisMetabolic ReprogrammingLactic AcidFluorodeoxyglucose F18Citric Acid CycleGlucose Transport Proteins, Facilitative

Stichwörter der Autor:innen

Warburg effectbutyratecolorectal cancerglucose transportersmetabolic reprogramming

Substanzen

ButyratesLactic AcidFluorodeoxyglucose F18Glucose Transport Proteins, Facilitative

Autor:innen und Institutionen

  • Univ Coimbra, Coimbra Institute for Clinical and Biomedical Research (iCBR) area of Environment Genetics and Oncobiology (CIMAGO), Biophysics Institute of Faculty of Medicine, 3000-548 Coimbra, Portugal.
  • Univ Coimbra, Faculty of Pharmacy, 3000-548 Coimbra, Portugal.
  • Univ Coimbra, Center for Innovative Biomedicine and Biotechnology (CIBB), 3000-548 Coimbra, Portugal.
  • Clinical Academic Center of Coimbra (CACC), 3004-561 Coimbra, Portugal.
  • Univ Coimbra, Coimbra Institute for Clinical and Biomedical Research (iCBR) area of Environment Genetics and Oncobiology (CIMAGO), Laboratory of Oncobiology and Hematology and University Clinics of Hematology and Oncolo…
  • Univ Coimbra, CNC-Center for Neuroscience and Cell Biology, 3004-504 Coimbra, Portugal.

ORCID-Profile: Ana Margarida Abrantes, Ana Salomé Pires, Ana Cristina Gonçalves, Ludgero Canário Tavares, Ana Bela Sarmento-Ribeiro, Maria Filomena Botelho

Förderung

  • Fundação para a Ciência e Tecnologia

Zitieren

APA

Gonçalves, T. J., Abrantes, A. M., Pires, A. S., Gonçalves, A. C., Tavares, L. C., Casalta-Lopes, J., Sarmento-Ribeiro, A. B., Carvalho, R. A., & Botelho, M. F. (2026). Preventive Effect of Butyrate in Colon Cancer Cell Metabolism. International Journal of Molecular Sciences, 27(8), 3696. https://doi.org/10.3390/ijms27083696

Vancouver

Gonçalves TJ, Abrantes AM, Pires AS, Gonçalves AC, Tavares LC, Casalta-Lopes J, et al. Preventive Effect of Butyrate in Colon Cancer Cell Metabolism. International Journal of Molecular Sciences. 2026;27(8):3696. doi:10.3390/ijms27083696

BibTeX
@article{Gonalves2026,
  author = {Gonçalves, Telmo José and Abrantes, Ana Margarida and Pires, Ana Salomé and Gonçalves, Ana Cristina and Tavares, Ludgero Canário and Casalta-Lopes, João and Sarmento-Ribeiro, Ana Bela and Carvalho, Rui A and Botelho, Maria Filomena},
  title = {Preventive Effect of Butyrate in Colon Cancer Cell Metabolism},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {8},
  pages = {3696},
  doi = {10.3390/ijms27083696}
}
Kostenlos starten →